Other ingredients: Bulking Agent, Binder, Lubricant, Hydroxy Propyl Methylcellulose Capsules, Capsule Shell Ingredient (INS 464), Diluent (INS 460 (i)), Thickening Agent (INS 462), Glidant (INS 553 (iii)), Anti-Caking Agent (INS 551) & Emulsifier (INS 470 (i))
.webp)
International Journal of Molecular Sciences, 2025 DOI: 10.3390/ijms262411774 #MultipleSclerosis #Neuroimmunology #Biomarkers #OCT #DisabilityProgression #ClinicalResearch #Neurology To view or add a comment, sign in Exploring extracellular vesicles as diagnostic tools in gutbrain axis disorders: in this concise review article, Patricia Maral da Costa, Reinaldo Barreto Ori at Federal University of Ceara and collaborators integrated microbial- and brain-derived extracellular vesicles within the framework of gutbrain axis disorders and proposed three translational diagnostic niches: microbial EVs as systemic indicators of dysbiosis and immune activation, brain-derived EVs as liquid biopsies of central nervous system pathology, and engineered or technologically captured EVs as platforms for point-of-care testing

Early exploratory analyses suggest that 3040% of participants in some trials may achieve formal diabetes remission criteria (near-normal HbA1c without additional glucose-lowering therapy), although these figures need to be confirmed in larger phase 3 populations
Were ready to help